title: Differences in nucleotide effects on intracellular pH, Na+/H+ antiport activity, and ATP-binding proteins in endothelial cells.
abstract: Bovine (BPAEC) and human (HPAEC) pulmonary artery endothelial cell monolayers were incubated with either ATP, ATP analogues, or UTP, followed by measurement of intracellular pH (pHi) and the rate of recovery from acidosis. ATP increased baseline pHi and the rate of acid recovery in BPAEC. This response was inhibited by the amiloride analogue, methyisobutylamiloride, demonstrating that activation of the Na+/H+ antiport was responsible for the increase in baseline pHi and the recovery from acidosis. This response had the features of both a P2Y and P2U purinergic receptor, based on the responses to a series of ATP analogues and UTP. In contrast, none of the nucleotides had any significant effect on pHi and Na+/H+ antiport activity in HPAEC. This difference in the response to extracellular nucleotides was not due to a difference in ATP metabolism between cell types, since the ectonucleotidase-resistant analogue. ATP gamma S, also had no effect on HPAEC. Analogues of cAMP had no effect on pHi or acid recovery in either cell type. Incubation of BPAEC and HPAEC with the photoaffinity ligand [32P] 8-AzATP indicated that both BPAEC and HPAEC possess an ATP-binding protein of 48 kDa. However, BPAEC exhibited an additional binding protein of 87 kDa. Thus, the contrasting response to extracellular ATP between bovine and human pulmonary artery endothelial cells may be related to differences in the signal transduction pathway leading to antiport activation, including different ATP-binding sites on the cell membrane.
authors.affiliation: Veterans Administration Medical Center, Brown University School of Medicine, Providence, Rhode Island, USA.
authors.forename: M
authors.initials: M
authors.lastname: Cutaia
authors.forename: D D
authors.initials: DD
authors.lastname: Dawicki
authors.forename: L M
authors.initials: LM
authors.lastname: Papazian
authors.forename: N
authors.initials: N
authors.lastname: Parks
authors.forename: E
authors.initials: E
authors.lastname: Clarke
authors.forename: S
authors.initials: S
authors.lastname: Rounds
mesh_terms: D000255:Adenosine Triphosphate / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D000345:Affinity Labels; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002352:Carrier Proteins / Q000378:metabolism*; D002417:Cattle; D002462:Cell Membrane / Q000378:metabolism; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009711:Nucleotides / Q000494:pharmacology*; D010777:Photochemistry; D011651:Pulmonary Artery; D017923:Sodium-Hydrogen Exchangers / Q000378:metabolism*; D014544:Uridine Triphosphate / Q000494:pharmacology
chemical_list: D000345:Affinity Labels; D002352:Carrier Proteins; D009711:Nucleotides; D017923:Sodium-Hydrogen Exchangers; D000255:Adenosine Triphosphate; D000242:Cyclic AMP; D002118:Calcium; D014544:Uridine Triphosphate